The MoU for the Iodine Deficiency Disorders Control Programme, earlier known as Goitre control Programme was signed on August 3 last year during the visit of Prime Minister Narendra Modi.
Indian Ambassador to Nepal Ranjit Rae handed over a cheque of Rs 51.75 million (Rs 32.38 million) to Nepal Minister of Commerce and Supplies Sunil Bahadur Thapa for execution of the project which is carried out by the state-owned Salt Trading Corporation of Nepal
An impact study commissioned by India indicated that the programme has been successful in nearly eradicating visible goitre and reducing the incidence of other iodine deficiency disorders in Nepal.
India-Nepal cooperation in the health sector includes creation of health infrastructure ranging from development of major hospitals to opening of numerous health posts covering the farthest corners of Nepal, supply of medicines and medical equipment, providing faculty support to various medical institutions.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
